Zheng et al., 2022 - Google Patents
Lymph node ratio is a superior predictor in surgically treated early-onset pancreatic cancerZheng et al., 2022
View HTML- Document ID
- 12773806717544838954
- Author
- Zheng Y
- Lu Z
- Shi X
- Tan T
- Xing C
- Xu J
- Cui H
- Song J
- Publication year
- Publication venue
- Frontiers in Oncology
External Links
Snippet
Background The prognostic performance of four lymph node classifications, the 8th American Joint Committee on Cancer (AJCC) Tumor Node Metastasis (TNM) N stage, lymph node ratio (LNR), log odds of positive lymph nodes (LODDS), and examined lymph nodes …
- 210000001165 Lymph Nodes 0 title abstract description 87
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Morikawa et al. | Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer | |
Liu et al. | Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study | |
Hanai et al. | The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer | |
Gokce et al. | Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance | |
Huang et al. | Inflammation markers have important value in predicting relapse in patients with papillary thyroid carcinoma: a long-term follow-up retrospective study | |
Jiang et al. | CCT6A, a novel prognostic biomarker for Ewing sarcoma | |
Chen et al. | The geriatric nutritional risk index is an effective tool to detect GLIM-defined malnutrition in rectal cancer patients | |
Lehtinen et al. | REG4 is highly expressed in mucinous ovarian cancer: a potential novel serum biomarker | |
Wang et al. | Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker | |
Zheng et al. | Lymph node ratio is a superior predictor in surgically treated early-onset pancreatic cancer | |
Zhang et al. | HALP score based on hemoglobin, albumin, lymphocyte and platelet can predict the prognosis of tongue squamous cell carcinoma patients | |
Snell et al. | Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification | |
Gao et al. | Number of positive lymph nodes is superior to LNR and LODDS for predicting the prognosis of pancreatic neuroendocrine neoplasms | |
Li et al. | Natural killer cell-related prognosis signature predicts immune response in colon cancer patients | |
Turri et al. | Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer | |
Zhang et al. | Preoperative plasma fibrinogen level represents an independent prognostic factor in a Chinese cohort of patients with upper tract urothelial carcinoma | |
Fu et al. | LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study | |
Yang et al. | A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer | |
Yang et al. | The prognostic significance of the fibrinogen-to-albumin ratio in patients with triple-negative breast cancer: a retrospective study | |
Liang et al. | Log odds of positive lymph nodes show better predictive performance on the prognosis of early-onset colorectal cancer | |
Wang et al. | Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy | |
Zhao et al. | Three inflammation‐related genes could predict risk in prognosis and metastasis of patients with breast cancer | |
Wei et al. | A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients | |
Shi et al. | Development and validation of lymph node ratio-based nomograms for primary duodenal adenocarcinoma after surgery | |
Cui et al. | Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction |